Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth

Koji Taniguchi1, Takuma Ishizaki, Toranoshin Ayada

  • 1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

Cancer Science
|June 5, 2009
PubMed

Insights

Sprouty4 acts as a tumor suppressor by inhibiting blood vessel growth. Its absence in knockout mice accelerates tumor development and blood vessel formation, highlighting its role in regulating angiogenesis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Physiology

Background:

  • Sprouty proteins negatively regulate receptor tyrosine kinase (RTK) signaling pathways.
  • Sprouty proteins are recognized for their tumor suppressor functions.
  • The in vivo pathophysiological roles of Sproutys require further investigation.

Purpose of the Study:

  • To investigate the physiological function of Sprouty4 as an angiogenic regulator.
  • To utilize Sprouty4 knockout (KO) mice and cells to examine its role in angiogenesis.

Main Methods:

  • Tumorigenicity assays in Sprouty4 KO and wild type (WT) mice.
  • Assessment of neovascularization in transplanted tumors.
  • In vivo and ex vivo angiogenesis assays using vascular endothelial growth factor-A (VEGF-A), basic fibroblast growth factor (bFGF), and sphingosine-1-phosphate (S1P).
  • Analysis of Sprouty4's effect on Ras-independent (VEGF-A, S1P) and Ras-dependent (VEGF-C) signaling pathways.

Main Results:

  • Transplanted tumor cells exhibited significantly faster growth in Sprouty4 KO mice compared to WT mice.
  • Enhanced neovascularization was observed in tumors grown in Sprouty4 KO mice.
  • VEGF-A-induced angiogenesis and vascular permeability were increased in Sprouty4 KO mice.
  • Ex vivo angiogenesis in aortic explants was enhanced in Sprouty4 KO mice.
  • Sprouty4 was found to suppress Ras-independent VEGF-A and S1P signaling but not Ras-dependent VEGF-C signaling.

Conclusions:

  • Sprouty4 selectively suppresses Ras-independent angiogenic factor signals.
  • Sprouty4 functions as a critical negative regulator of pathophysiological angiogenesis.
  • These findings underscore the importance of Sprouty4 in controlling tumor growth and vascularization.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...